The effort to develop an Ebola vaccine has made progress recently, but too late to save those who died during last year's epidemic. Scientists are now racing to find a vaccine against the Zika virus. Andrew Ward, FT pharmaceuticals correspondent, asks Charlie Weller of the Wellcome Trust why scientists are so often behind the curve. Music by David Sappa

Read more on vaccines in an FT Special Report at ft.com/vaccines

iTunes Stitcher audioBoom SoundCloud Overcast RSS


Copyright The Financial Times Limited 2017. All rights reserved.
myFT

Follow the topics related to this show

Comments have not been enabled for this podcast.